Biochemical and Inflammatory Markers in Covid-19 Patients of a Tertiary Care Hospital at North Karnataka – A Descriptive Study

Автор: M. N. Astagimath, Raviraja A., Suman Doddamani

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 3 т.17, 2021 года.

Бесплатный доступ

Background: Covid-19 has emerged as a public health crisis. Biochemical and laboratory parameters play a role in understanding the disease process. Aims and objectives: 1. Understanding the demographic pattern of Covid-19 disease in the study population. 2. To analyze biochemical and inflammatory markers in Covid-19 patients. Study includes the data collected from Covid -19 Hospital laboratory of a tertiary care hospital at KIMS (Karnataka Institute of medical sciences, Hubballi, Karnataka, India). Data was collected from March to October 2020 (Total 7800 patients had Covid-19 during this period). The present study includes the data from the 4478 Covid-19 patients of age group ranging from 1year to 99 years. Newborn to Covid-19 positive mothers and patients whose complete data was not available were excluded from the study. The parameters included in the study are CRP(c reactive protein), Ferritin, LDH (Lactate dehydrogenase), Troponin-I, and D-dimer. Results: The levels of CRP, LDH, Ferritin were significantly increased in males compared to females. There was a significant difference in the levels of CRP, LDH, Ferritin, and D-dimer among different age groups, but no such statistical difference was found for Troponin-I. Conclusion: This study suggests the possibility of increase in severity of the disease with increasing age. This possibility of association between age and severity of disease was earlier studied only on small sample size. This study also suggests that disease severity is more common in males than in females.

Еще

CRP, LDH, Troponin-I, Ferritin, D-dimer

Короткий адрес: https://sciup.org/143173907

IDR: 143173907

Список литературы Biochemical and Inflammatory Markers in Covid-19 Patients of a Tertiary Care Hospital at North Karnataka – A Descriptive Study

  • Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SYet al. Guidelines for Laboratory Diagnosis ofCoronavirus Disease 2019 (COVID-19) in Korea.Annals of laboratory medicine. 2020;40(5):351-60.
  • https://www.statnews.com/2020/03/11/who.
  • https://www.worldometers.info/coronavirus.
  • Gong J, Dong H, Xia SQ, Huang Y, Wang Z, ZhaoY et al. Correlation analysis between diseaseseverity and patients inflammation-relatedparameters in with Covid-19 Pneumonia. medRxiv.2020; 20025643.
  • J. Sepulveda. Challenges in Routine ClinicalChemistry Analysis: Proteins and Enzymes. In: A.Dasgupta, J. L. Sepulveda, eds.Accurate Results inthe Clinical Laboratory. Elsevier;2013:131-148.
  • McFadden RG, Oliphant LD. Serum lactatedehydrogenase in interstitial lung disease.Chest.1991;100(4):1182.
  • Antman EM. Decision making with cardiac troponintests. The New England journal ofmedicine.2002;346(26):2079-82.
  • Smith SC, Ladenson JH, Mason JW, Jaffe AS.Elevations of cardiac Troponin-I associated withmyocarditis: experimental and clinical correlates.Circulation. 1997;95(1):163–168.
  • Knovich MA, Storey JA, Coffman LG, Torti SV, TortiFM. Ferritin for the clinician. Bloodreviews.2009;23(3):95-104.
  • Wei Wang, Mary Ann Knovich, Lan G.Coffman,Frank M. Torti,and Suzy V. Torti. SerumFerritin: Past, Present and Future. Biochim BiophysActa. 2010;1800(8):760–769.
  • Armaghan Y. Soomro, Alejandra Guerchicoff, DruJ. Nichols, Javed Suleman, George D. Dangas.The current role and future prospects of the Ddimerbiomarker. European Heart Journal -Cardiovascular Pharmacotherapy. 2016;2(3):175–184.
  • L.A. Linkins Takach Lapner. Review of D‐dimertesting: Good, Bad, and Ugly. International Journalof Laboratory Haematology.2017;39(1):98–103.
  • Wang L. C-reactive protein levels in the early stageof COVID-19. Med Mal Infect. 2020;50(4):332-334.
  • Trupti Bajpai, Prachi Shaw, and Ravi Dosi.Evaluation of C-Reactive protein levels amongCovid-19 patients. European Journal OfPharmaceutical And Medical Research.2020;07(07):618-21.
  • Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C.C-reactive protein as an early predictor of COVID19 severity. Journal of medicalbiochemistry.2020;39(4):500-7.
  • L. Szarpak, K. Ruetzler, K. Safiejko. Lactatedehydrogenase level as a COVID-19 severitymarker. American Journal of Emergency Medicine.Nov 2020.
  • Lukasz Szarpak, Kurt Ruetzler, Kamil Safiejko,Michal Hampel, Michal Pruc, Luiza Kanczuga -Koda, Krzysztof Jerzy Filipiak, and Milosz JaroslawJaguszewski. Lactate dehydrogenase level as aCOVID-19 severity marker. American Journal ofEmergency Medicine.2020(10):1016.
  • Hu J, Zhou J, Dong F, Tan J, Wang S, Li Z et al.Combination of serum lactate dehydrogenase andsex is predictive of severe disease in patients withCOVID-19. Medicine.2020;99(42):22774.
  • Tersalvi G, Vicenzi M, Calabretta D, Biasco L,Pedrazzini G, Winterton D. Elevated Troponin inPatients With Coronavirus Disease 2019:PossibleMechanisms. Journal of cardiacfailure.2020;26(6):470-5.
  • Bing-Cheng Zhao, Wei-Feng Liu, Shao-Hui Lei, Bo-Wei Zhou, Xiao Yang, Tong-Yi Huang etal.Prevalence and prognostic value of elevatedtroponins in patients hospitalized for coronavirusdisease 2019: a systematic review and metaanalysis.Journal of Intensive Care.2020;8:88.
  • Sinem Ozyılmaz, Esra Ergun Al, Emrah Ermi,Samir Allahverdiyev and Hakan Uçar. Assessmentof the Relationship between Mortality and Troponin-I Levels in Hospitalized Patients with the NovelCoronavirus (COVID-19). Medicina.2020;56:693.
  • Shani Dahan, Gad Segal, Itai Katz, Tamar Hellou,Michal Tietel, Gabriel Bryk et al. Ferritin as aMarker of Severity in COVID-19 Patients: A FatalCorrelation. Isreal Medical AssociationJournal.2020;Aug 22(8):494-500.
  • Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M.Serum ferritin as an independent risk factor forseverity in COVID-19 patients. The Journal ofinfection.2020;81(4):647-79.
  • Gandini O, Criniti A, Gagliardi MC, Ballesio L,Giglio S, Balena A et al.Sex-disaggregated dataconfirm serum ferritin as an independent predictorof disease severity both in male and femaleCOVID-19 patients. The Journal of infection.2021;82(3):414-51.
  • Panagiotis Paliogiannis, Arduino AleksanderMangoni, Paola Dettori , Gheyath K. Nasrallah,Gianfranco Pintus et al. D-Dimer Concentrationsand COVID-19 Severity: A Systematic Review andMeta-Analysis. Infectious diseases – surveillance,prevention and treatment.Aug 2020.
  • Panagiotis Paliogiannis, Arduino AleksanderMangoni, Paola Dettori, Gheyath K. Nasrallah,Gianfranco Pintus and Angelo Zinellu. D-DimerConcentrations and COVID-19 Severity: ASystematic Review and Meta-Analysis. PublicHealth.04 August 2020.
Еще
Статья научная